Skip to content

Friday, July 26, 2024

Latest:

Reflections on medical advocacy
Congratulations, Dr. James R. Lupski, 2024 Mendel Lecturer and recipient of the Gilded Pea Award!
Benefits of low impact workouts: Pilates, dance and barre
Eating healthy on a budget: Tips and tricks from a registered dietitian
Defective serotonin 2C receptors lead to memory deficits in mice and humans

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

HEROS clinical trial

nci-ewing-sarcoma

CAR T cell therapy targeting HER2 antigen shows promise against advanced sarcoma in phase I clinical trial

May 21, 2024 CARTcell therapy, HEROS clinical trial, Research, sarcoma

The HEROS 2.0 trial showed that this therapeutic approach is safe and is associated with clinical benefit.

From the Labs: Image of the Month

From the Labs: The wooly mammoth emerges from the past.

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951